Article
Metabolic remodeling by RNA polymerase gene mutations is associated with reduced β-lactam susceptibility in oxacillin-susceptible MRSA.
mBio - 12 Jun 2024
Watanabe Shinya, Nsofor Chijioke A, Thitiananpakorn Kanate, Tan Xin-Ee, Aiba Yoshifumi, Takenouchi Remi, Kiga Kotaro, Sasahara Teppei, Miyanaga Kazuhiko, Veeranarayanan Srivani, Shimamori Yuzuki, Lian Adeline Yeo Syin, Nguyen Thuy Minh, Nguyen Huong Minh, Alessa Ola, Kumwenda Geoffrey Peterkins, Jayathilake Sarangi, Revilleza Jastin Edrian Cocuangco, Baranwal Priyanka, Nishikawa Yutaro, Li Feng-Yu, Kawaguchi Tomofumi, Sankaranarayanan Sowmiya, Arbaah Mahmoud, Zhang Yuancheng, Maniruzzaman, Liu Yi, Sarah Hossain, Li Junjie, Sugano Takashi, Ho Thi My Duyen, Batbold Anujin, Nayanjin Tergel, Cui Longzhu
Abstract excerpt
The emergence of oxacillin-susceptible methicillin-resistant Staphylococcus aureus (OS-MRSA) has imposed further challenges to the clinical management of MRSA infections. When exposed to β-lactam antibiotics, these strains can easily acquire reduced β-lactam susceptibility through chromosomal mutations, including those in RNA polymerase (RNAP) genes such as rpoBC, which may then lead to treatment failure. Despite...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
